431 related articles for article (PubMed ID: 17875900)
1. Necrolytic migratory erythema: the outermost marker for glucagonoma syndrome.
Gantcheva ML; Broshtilova VK; Lalova AI
Arch Dermatol; 2007 Sep; 143(9):1221-2. PubMed ID: 17875900
[No Abstract] [Full Text] [Related]
2. Migratory necrolytic erythema and glucagonoma.
Echenique-Elizondo M; Elorza JL; De Delas JS
Surgery; 2003 Apr; 133(4):449-50. PubMed ID: 12717367
[No Abstract] [Full Text] [Related]
3. A patient with long-standing skin lesions. Necrolytic migratory erythema.
Netea RT; Erceg A; Pieters G; Hermus AR
Neth J Med; 2004 Dec; 62(11):453, 462. PubMed ID: 15685896
[No Abstract] [Full Text] [Related]
4. Differentiating non-paraneoplastic from glucagonoma associated necrolytic migratory erythema.
Rohna R; Suraiya HH
Singapore Med J; 1998 Aug; 39(8):385. PubMed ID: 9844504
[No Abstract] [Full Text] [Related]
5. Necrolytic migratory erythema: first symptom of a glucagonoma. A case report.
Du Jardin P; Cools P; Van der Stighelen Y
Acta Chir Belg; 2004 Aug; 104(4):468-70. PubMed ID: 15469167
[TBL] [Abstract][Full Text] [Related]
6. Necrolytic migratory erythema with myelodysplastic syndrome without glucagonoma.
Technau K; Renkl A; Norgauer J; Ziemer M
Eur J Dermatol; 2005; 15(2):110-2. PubMed ID: 15757825
[TBL] [Abstract][Full Text] [Related]
7. [Necrolytic migratory erythema in glucagonoma syndrome (author's transl)].
Kitoh M; Ohyama K; Shigeo ; Arao AT
Nihon Hifuka Gakkai Zasshi; 1981 Apr; 91(5):559-68. PubMed ID: 6270429
[No Abstract] [Full Text] [Related]
8. What is your diagnosis? Necrolytic migratory erythema associated with a glucagonoma.
Chaw L; Krop TM; Hood AF
Cutis; 2008 Jan; 81(1):25, 30-2. PubMed ID: 18306843
[No Abstract] [Full Text] [Related]
9. [Erythema necroticans migrans without glucagonoma].
Tanner M; Brasch J; Christophers E
Hautarzt; 1994 Jul; 45(7):480-3. PubMed ID: 7928344
[TBL] [Abstract][Full Text] [Related]
10. Necrolytic migratory erythema.
Kovács RK; Korom I; Dobozy A; Farkas G; Ormos J; Kemény L
J Cutan Pathol; 2006 Mar; 33(3):242-5. PubMed ID: 16466513
[TBL] [Abstract][Full Text] [Related]
11. [Necrolytic migratory erythema: glucagonoma syndrome. Clinical and histological aspects].
Wilkinson DS
Ann Med Interne (Paris); 1984; 135(8):654-7. PubMed ID: 6099068
[TBL] [Abstract][Full Text] [Related]
12. Necrolytic migratory erythema associated with glucagonoma treated successfully with cyclosporine.
Jiménez-Gallo D; Ossorio-García L; de la Varga-Martínez R; Arjona-Aguilera C; Linares-Barrios M
Dermatol Ther; 2017 Jul; 30(4):. PubMed ID: 28508546
[No Abstract] [Full Text] [Related]
13. Images in clinical medicine. Necrolytic migratory erythema.
McGevna L; Tavakkol Z
N Engl J Med; 2010 Jan; 362(1):e1. PubMed ID: 20054043
[No Abstract] [Full Text] [Related]
14. Pancreatic glucagonoma presenting as necrolytic migratory erythema.
Colombo E; Zuccoli R; Ugolini M; Dardano F; Leigheb G
J Clin Oncol; 2007 May; 25(15):2135-6. PubMed ID: 17513822
[No Abstract] [Full Text] [Related]
15. A serpiginous eruption.
Esdaile BA; Hollowood K; Burge S
Arch Dermatol; 2012 Mar; 148(3):385-90. PubMed ID: 22431782
[No Abstract] [Full Text] [Related]
16. Necrolytic migratory erythema associated with glucagonoma syndrome.
Shi W; Liao W; Mei X; Xiao Q; Zeng Y; Zhou Q
J Clin Oncol; 2010 Jul; 28(20):e329-31. PubMed ID: 20530273
[No Abstract] [Full Text] [Related]
17. [The glucagonoma syndrome].
Levitskaia ZI; Balabolkin MI; Gordina AA; Goriainova II; Tatochenko KV
Sov Med; 1985; (9):120-3. PubMed ID: 2999999
[No Abstract] [Full Text] [Related]
18. [Necrolytic migratory erythema. A marker of systemic disease].
de Cristancho NP; Rivera J; de Arriaga AD
Rev Clin Esp; 1994 Aug; 194(8):654. PubMed ID: 7938851
[No Abstract] [Full Text] [Related]
19. Iatrogenic necrolytic migratory erythema: a case report and review of nonglucagonoma-associated necrolytic migratory erythema.
Mullans EA; Cohen PR
J Am Acad Dermatol; 1998 May; 38(5 Pt 2):866-73. PubMed ID: 9591806
[TBL] [Abstract][Full Text] [Related]
20. [Facial erythema and pancreatic glucagonoma].
Erce C; Morales DJ; Diego L; Mazorra F; García de Polavieja M
Rev Esp Enferm Dig; 1997 Feb; 89(2):137-8. PubMed ID: 9115822
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
